Comment reveals benefits of integrated care in inflammatory bowel disease in Northern Ireland, suggesting improvements for immune-mediated diseases.
Teaser Text We read with interest the article published by He. et al and commend the authors for their clear and compelling arguments for establishing collaborative clinics for patients affected by Inflammatory Bowel Disease. We respond to report real-world benefits and challenges of adopting an integrated care approach for patients affected by the broader spectrum of immune-mediated-inflammatory diseases (IMID), by sharing our experience from an interdisciplinary Dermatology-Rheumatology-Gastroenterology clinic in a large Healthcare Trust in Northern Ireland.
No takes yet. Share an insight, caveat, or question.
Boyd et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: